Literature DB >> 16680213

Emerging psychosis in young people - Part 3 - key issues for prolonged recovery.

Richard Fraser1, Gregor Berger, Eoin Killackey, Patrick McGorry.   

Abstract

BACKGROUND: After 18 months of specialist care only about half of all first episode psychosis patients achieve functional recovery, and about 10-20% patients will not respond to initial treatment and have persistent psychotic symptoms. These patients need special attention in order to minimise the burden of disease and prolonged disability.
OBJECTIVE: This article reviews the management of young first episode psychosis patients with incomplete recovery, and focuses on the general practitioner's role, how to deal with treatment resistance, vocational rehabilitation, and other aspects of patient care. DISCUSSION: Once the acute episode has been treated, it is important to avoid complacency and address other aspects contributing to a patient's wellbeing including social welfare, physical health and vocational rehabilitation. The prevention of relapse and the psychosocial development of the individual are key in fostering and promoting a healthy lifestyle, leading to improved quality of life. Treatment refractory patients need specialist care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680213

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  6 in total

1.  A Comparison of Vocational Engagement Among Young People with Psychosis, Depression and Borderline Personality Pathology.

Authors:  E Caruana; S M Cotton; J Farhall; E M Parrish; A Chanen; C G Davey; E Killackey; K Allott
Journal:  Community Ment Health J       Date:  2017-11-20

Review 2.  Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics.

Authors:  Pierre Chue; Robin Emsley
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 3.  Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment.

Authors:  Patrick D McGorry
Journal:  Neurotox Res       Date:  2010-04-03       Impact factor: 3.911

4.  Role of long-acting injectable second-generation antipsychotics in the treatment of first-episode schizophrenia: a clinical perspective.

Authors:  Radovan Přikryl; Hana Přikrylová Kučerová; Michaela Vrzalová; Eva Cešková
Journal:  Schizophr Res Treatment       Date:  2012-05-07

Review 5.  Unmet needs in the management of schizophrenia.

Authors:  Francisco Torres-González; Inmaculada Ibanez-Casas; Sandra Saldivia; Dinarte Ballester; Pamela Grandón; Berta Moreno-Küstner; Miguel Xavier; Manuel Gómez-Beneyto
Journal:  Neuropsychiatr Dis Treat       Date:  2014-01-16       Impact factor: 2.570

6.  "Everyone Needs a Friend Sometimes" - Social Predictors of Long-Term Remission In First Episode Psychosis.

Authors:  Jone Bjornestad; Inge Joa; Tor K Larsen; Johannes Langeveld; Larry Davidson; Wenche Ten Velden Hegelstad; Liss G Anda; Marius Veseth; Ingrid Melle; Jan O Johannessen; Kolbjorn Bronnick
Journal:  Front Psychol       Date:  2016-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.